Radiopharmaceutical therapy of bone metastases with 89SrCl2, 186Re-HEDP and 153Sm-EDTMP: a dosimetric study using Monte Carlo simulation-Reference-Cited by-同舟云学术

Radiopharmaceutical therapy of bone metastases with 89SrCl2, 186Re-HEDP and 153Sm-EDTMP: a dosimetric study using Monte Carlo simulation

Published:2007-01-20 Issue:7 Volume:34 Page:1031-1038
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Strigari L.,Sciuto R.,D’Andrea M.,Pasqualoni R.,Benassi M.,Maini C. L.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-006-0302-4.pdf

Reference48 articles.

1. Twicross RG, Fairfield S. Pain in advanced cancer. Pain 1982;14:303–10.

2. Coleman RE. Skeletal complications of malignancy. Cancer 1997;80:1588–94.

3. Slatkin N. Cancer-related pain and its pharmacological management in the patient with bone metastasis. J Support Oncol 2006;4(2 Suppl 19):15–21.

4. Lewington VJ. Bone seeking radionuclides for therapy. J Nucl Med 2005;46:38S–47S.

5. Sciuto R, Festa A, Rea S, Pasqualoni R, Bergomi S, Petrilli G, et al. Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial. J Nucl Med 2002;43:79–86.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A solvent extraction-based procedure for removal of 46Sc impurity from reactor produced [45Ca]CaCl2 for its potential use in bone pain palliation;Applied Radiation and Isotopes;2022-10

2. Bone marrow dosimetry for 141Ce-EDTMP as a potential bone pain palliation complex: A Monte Carlo study;Applied Radiation and Isotopes;2022-04

3. Dosimetric evaluation of several candidate radionuclides used in radionuclide therapy of bone metastases in an upper leg model;Radiation Physics and Chemistry;2020-11

4. Comparison between Targeted Radionuclide Therapy of Bone Metastases Based on β-Emitting and α-Emitting Radionuclides;Journal of Medical Imaging and Radiation Sciences;2019-06

5. A radiobiological model of metastatic burden reduction for molecular radiotherapy: application to patients with bone metastases;Physics in Medicine and Biology;2017-03-14